tiprankstipranks
Ensysce leadership participates at Annual Pain Therapeutics Summit
PremiumThe FlyEnsysce leadership participates at Annual Pain Therapeutics Summit
2M ago
Ensysce Biosciences responds to recent shareholder inquiries
Premium
The Fly
Ensysce Biosciences responds to recent shareholder inquiries
2M ago
Ensysce Biosciences receives Nasdaq notice
Premium
The Fly
Ensysce Biosciences receives Nasdaq notice
2M ago
Ensysce Biosciences to sell 3.55M shares at 47c in registered direct offering
PremiumThe FlyEnsysce Biosciences to sell 3.55M shares at 47c in registered direct offering
3M ago
Ensysce Biosciences receives $14M NIH grant for novel opioid development
Premium
The Fly
Ensysce Biosciences receives $14M NIH grant for novel opioid development
3M ago
ENSC Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ENSC Upcoming Earnings Report: What to Expect?
4M ago
Ensysce Biosciences selects PF9001 to move into IND-enabling studies
PremiumThe FlyEnsysce Biosciences selects PF9001 to move into IND-enabling studies
6M ago
Ensysce Biosciences regains compliance with Nasdaq
Premium
The Fly
Ensysce Biosciences regains compliance with Nasdaq
6M ago
Ensysce Biosciences renews collaboration with Quotient Sciences
Premium
The Fly
Ensysce Biosciences renews collaboration with Quotient Sciences
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100